VK-0214 is an agonist for thyroid beta receptor (TRbeta), which ameliorates the X-linked adrenoleukodystrophy (X-ALD), through activation of ABCD2 expression and reduction of very long chain fatty acids (VLCFA) accumulation[1].
Molecular Weight:
412.42
Purity:
99.74
CAS Number:
[852949-30-5]
Formula:
C23H25O5P
Target:
Thyroid Hormone Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted